S99.239S Salter-Harris Type III physeal fracture of phalanx of unspecified toe, sequela

Name of the Condition

• Salter-Harris Type III physeal fracture of phalanx of unspecified toe, sequela

Summary

This condition represents a Salter-Harris Type III physeal fracture of an unspecified toe phalanx, classified as a sequela. This type of fracture involves a fracture line extending through the growth plate (physis) and into the epiphysis (the end of the bone), typically occurring in children or adolescents. The "sequela" designation indicates residual effects or complications following the initial injury, requiring ongoing evaluation to monitor healing and growth.

Causes

Direct trauma or injury to the toe, such as falls, sports-related impacts, or accidents, can disrupt the growth plate. Sudden force applied to the phalanges, including stubbing, crushing, or twisting, may lead to this type of fracture. The sequela status reflects the long-term consequences of the initial injury, which may include persistent pain, deformity, or functional limitations.

Risk Factors

• Age: Children and adolescents, as their growth plates are still developing and more susceptible to injury.
• High-impact activities: Participation in sports like running, jumping, or contact sports.
• Previous injuries: Prior damage to the toes or surrounding structures may increase vulnerability.
• Poor footwear: Shoes that do not fit properly or lack support can increase toe injury risk.
• Inadequate initial treatment: Improper management of the original fracture may contribute to sequela development.

Symptoms

• Persistent pain or discomfort in the affected toe.
• Limited range of motion or stiffness.
• Visible deformity or malalignment of the toe.
• Swelling or tenderness that does not resolve with time.
• Difficulty bearing weight or walking on the foot.

Diagnosis

Physical examination to assess pain, swelling, and functional limitations. Imaging studies, such as X-rays or MRI, may be used to evaluate the fracture site and identify residual damage. The diagnosis confirms the sequela status by documenting persistent effects of the original injury, including abnormal bone growth or joint alignment.

Treatment Options

Treatment focuses on managing symptoms and addressing residual issues. This may include pain management, physical therapy to restore function, or orthopedic interventions to correct deformities. In some cases, surgical correction may be necessary to improve alignment or relieve persistent discomfort.

Prognosis and Follow-Up

Prognosis depends on the severity of the initial injury and the effectiveness of treatment. Regular follow-up is essential to monitor growth, alignment, and functional recovery. Long-term outcomes may include mild limitations in mobility or cosmetic changes, but most patients achieve satisfactory recovery with appropriate care.

Complications

• Growth disturbances: Abnormal bone growth due to damage to the growth plate.
• Chronic pain: Persistent discomfort affecting daily activities.
• Joint stiffness or arthritis: Long-term effects on toe mobility.
• Deformity: Visible misalignment of the toe or surrounding structures.

Lifestyle & Prevention

• Wear properly fitting, supportive footwear to protect toes during activities.
• Use protective gear during sports or high-impact activities.
• Avoid activities that increase toe injury risk, such as barefoot running on uneven surfaces.
• Maintain a healthy weight to reduce stress on the feet and toes.

When to Seek Professional Help

Seek medical attention if you experience persistent pain, swelling, or deformity in the toe, or if you notice difficulty walking or bearing weight. Early evaluation can help address complications and prevent further damage.

Tips for Medical Coders

This code is used for a Salter-Harris Type III physeal fracture of an unspecified toe phalanx, classified as a sequela. Documentation should clearly indicate the residual effects of the original injury, including any persistent symptoms, functional limitations, or anatomical changes. Ensure the code aligns with the patient's current clinical status and the nature of the sequela.